Navigation Links
BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
Date:2/28/2008

ARLINGTON, Va., Feb. 28 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and consulting firm serving the life science industry -- announces the publication of its latest report, "Conferences & Exhibits in the Life Sciences: What's Working Now." Exhibits at scientific conferences and trade shows are an essential element of the marketing mix, but calculating return on investment (ROI) remains elusive for most vendors. This unique report compares and contrasts the perspectives of scientific customers attending conferences with the objectives and expectations of leading life science exhibitors.

"Scientific conferences can be one of the most effective ways to get in front of a large number of customers and prospects," noted Tamara Zemlo, Ph.D., Director of Syndicated Research and Analysis at BioInformatics. "We created this report to address vendors' key questions about deciding which meetings are best to attend and exhibit at, how to budget for meetings, what booth elements attract scientists, and how to ensure the best return possible."

The report has a number of encouraging findings for scientific and lab equipment suppliers. Of the 1,000 life scientists who participated in the study, only 1% claim that they do not visit exhibit halls at scientific conferences, suggesting that, in theory, vendors have an opportunity to interact with almost all of the scientists in attendance. Additionally, 76% of the scientists surveyed report that visits to exhibit halls have influenced their purchase decisions in the past 12 months.

"Vendors providing the right kind of information that scientists need, who allow them to physically examine products, and who answer their questions in an unhurried manner will be better able to positively influence the products and instruments they buy for their labs," observed Dr. Zemlo.

In addition, scientists and vendors were asked to identify which conference organizers have the best exhibit halls. The American Association for Cancer Research and the Society for Neuroscience were ranked tops by both scientists and vendors; however, scientists and vendors reported different opinions with regard to 3rd and 4th place exhibit halls.

"While the top two choices were the same for both vendors and scientists, it's important to note that no single entity received the majority of votes for best exhibit hall," stated Dr. Zemlo. "Additionally, while write-in answers for the organizer of the best exhibit hall comprise 24% of vendors' answers, they constitute 41% of scientists' answers, reflecting the wide variety of conference options available to scientists."

This invaluable report provides suppliers and conference organizers with a roadmap for implementing a successful exhibition strategy. In "The Scientist Perspective" section, the beliefs and attitudes of 1,000 life scientists are featured, including how they select and why they attend scientific conferences as well as their expectations for exhibit halls. This section also provides information intended to help vendors attract scientists to their exhibit booths and tips to increase lead generation. In "The Vendor Perspective" section, marketing and sales executives from life science companies share their insights on how they select conferences to attend, exhibit and sponsor. This section also describes how vendors measure their conference ROI and how the emergence of new media may affect the future of trade show exhibiting.

"Conferences & Exhibits in the Life Sciences: What's Working Now" includes over 50 charts, tables and cross-tabulations of the survey data. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/189/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 36,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Catherine Seguin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

c.seguin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformations, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
4. Argonne researcher studies what makes quantum dots blink
5. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
6. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Promising Data ATIR Studies Presented by NIH Investigators
9. Clemson researcher studies carbon fibers for nuclear reactor safety
10. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
11. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):